Treatment Advocacy Center
Treatment Advocacy Center (TAC) is a national nonprofit organization dedicated to eliminating barriers to the timely and effective treatment of severe mental illnesses. The organization promotes laws, policies, and practices for the delivery of psychiatric care and supports the development of innovative treatments for and research into the causes of severe and persistent psychiatric illnesses, such as schizophrenia, bipolar disorder, and major depression.
History[edit]
The Treatment Advocacy Center was founded in 1998 by Dr. E. Fuller Torrey, a psychiatrist and researcher, in response to the growing need for a focused effort to improve treatment options for individuals with severe mental illnesses. The organization was established with the belief that many individuals with severe mental illnesses are unable to access adequate treatment due to systemic barriers, including laws that overly restrict involuntary treatment.
Mission and Goals[edit]
The primary mission of the Treatment Advocacy Center is to increase access to care for individuals with severe mental illnesses. The organization's goals include:
- Advocating for laws and policies that facilitate access to care for individuals with severe mental illnesses.
- Reducing barriers to the use of involuntary treatment for those who are unable to recognize their need for care due to their illness.
- Promoting the development of effective and innovative treatments for severe mental illnesses.
- Supporting research into the causes, treatment, and prevention of severe mental illnesses.
Programs and Initiatives[edit]
TAC is involved in various programs and initiatives aimed at improving the treatment of severe mental illnesses. These include:
- Legislative advocacy to support the enactment and implementation of laws that improve access to psychiatric care.
- Public education campaigns to raise awareness about severe mental illnesses and the need for improved treatment options.
- Research and reports on issues related to the treatment of severe mental illnesses, including the use of involuntary treatment and the availability of psychiatric beds.
Controversies and Criticism[edit]
The Treatment Advocacy Center's support for involuntary treatment has been a source of controversy. Critics argue that involuntary treatment infringes on individual rights and autonomy. TAC maintains that in certain cases, involuntary treatment is necessary to prevent harm to the individual or others and to enable individuals with severe mental illnesses to receive the care they need.
Impact[edit]
The Treatment Advocacy Center has been influential in the passage of laws and policies that improve access to treatment for individuals with severe mental illnesses. The organization's advocacy efforts have contributed to changes in state laws regarding involuntary treatment, increased funding for mental health services, and greater awareness of the challenges faced by individuals with severe mental illnesses and their families.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian